Status:
COMPLETED
Eye Detection to Identify Novel Coronavirus Infection
Lead Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Collaborating Sponsors:
Fudan University
Hubei Hospital of Traditional Chinese Medicine
Conditions:
Covid19
Eligibility:
All Genders
Up to 75 years
Brief Summary
The eye characteristics of patients with COVID-19 and those without the disease were analyzed, and whether they had the disease or not was judged according to the eye characteristics.
Detailed Description
To test the accuracy of a non-invasive eye monitoring that can be widely used for screening in judging patients with novel coronavirus infection.
Eligibility Criteria
Inclusion
- All participants were provided with written informed consent at the time of recruitment；
- Age ≥ 18 and ≤ 75 (informed consent signed by guardian under 18)
- Meet the diagnostic criteria of novel coronavirus (2019-COVID-19) infection
Exclusion
- Does not meet any of the inclusion criteria
Key Trial Info
Start Date :
January 22 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 26 2021
Estimated Enrollment :
232 Patients enrolled
Trial Details
Trial ID
NCT04907981
Start Date
January 22 2021
End Date
April 26 2021
Last Update
June 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shijiazhuang Fifth Hospital
Shijiazhuang, Hebei, China, 050024